Geode Capital Management, LLC Opiant Pharmaceuticals, Inc. Transaction History

Geode Capital Management, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 13, 2023	SELL	$9.38 - $20.29 $1,275 - $2,759	-136 Reduced 0.28%	48,591 $985,000
Q3 2022 Nov 14, 2022	BUY	$9.52 - $13.48 $1,589 - $2,251	167 Added 0.34%	48,727 $523,000
Q2 2022 Aug 12, 2022	BUY	$10.12 - $23.32 $5,687 - $13,105	562 Added 1.17%	48,560 $582,000
Q1 2022 May 13, 2022	SELL	$19.54 - $33.59 $43,886 - $75,443	-2,246 Reduced 4.47%	47,998 $1.03 Million
Q3 2021 Nov 12, 2021	BUY	$13.28 - $25.79 $496,167 - $963,565	37,362 Added 290.03%	50,244 $1.29 Million
Q1 2021 May 12, 2021	BUY	$8.2 - $14.49 $105,632 - $186,660	12,882 New	12,882 $136,000

300

Ticker OPNT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 5,164,150
Description
Opiant Pharmaceuticals, Inc., a specialty pharmaceutical company, develops medicines for addictions and drug overdose. The company offers NARCAN nasal spray, a treatment to reverse opioid overdoses. Its pipeline of product candidates includes medicines for the treatment for opioid overdose reversal; alcohol use disorders; acute cannabinoid overd...

Get notified when there are updates to the investment portfolio of Geode Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Geode Capital Management, LLC with notifications on news.